Fitch Ratings has said that the coronavirus is set to dampen china's economic growth.
Key notes
Ongoing coronavirus outbreak will dampen economic growth in China this year.
Chinese govt were to launch a large-scale stimulus to offset effects of coronavirus, it could have adverse effect on other policy goals.
Still too early to make definitive adjustments to china's GDP forecasts at this stage & instead have examined some illustrative scenarios.
Huge uncertainties remain over impact of coronavirus on china's economy.
China govt only likely launch large-scale stimulus if economic impact of virus proves substantially larger than sars outbreak in 2003.
This follows the prior 30 January 2020 report where it was stated:
- We at Fitch Solutions note the possibility of a revision to our China real GDP growth forecast within a range of 5.4%-5.9% for 2020.
- We do not rule out a downside risk beyond 5.4% as the economy is currently in a weaker position than it was in 2003 and has less policy space to weather the negative shock in the event of an extended and serious epidemic.
- Businesses, especially smaller ones already hit by de-leveraging, may struggle to survive and elevated closures could lead to higher unemployment over the coming months, a situation that would outlast the epidemic even if it were contained relatively quickly.
- We expect more fiscal stimulus to support the economy in order to achieve a very important goal for the Chinese government: 2020 is the deadline for China to double its economy relative to 2010.
- We believe policymaking will continue at full capacity despite cancellations of local political meetings in the run-up to the National People’s Congress typically held in March.
FX implications
It is still risk-on out there despite such warnings. AUD is better bid and the yen has been thrown back towards 110 vs the US dollar. US yields shot higher and US stocks bounced back with a vengeance. Investors are seeing through the initial shock to the world economy and figure that the reports of a breakthrough treatment for the coronavirus — despite scepticism from public health officials — as a cause for optimism, expecting that the deadly outbreak could be stopped before inflicting deeper economic wounds.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD stays below 1.1100, looks to post weekly losses
EUR/USD continues to trade in a narrow range below 1.1100 and remains on track to end the week in negative territory. Earlier in the day, monthly PCE inflation data from the US came in line with the market expectation, failing to trigger a reaction.
GBP/USD struggles to find a foothold, trades near 1.3150
GBP/USD stays on the back foot and trades in negative territory at around 1.3150 on Friday. The US Dollar holds its ground following the July PCE inflation data and doesn't allow the pair to stage a rebound heading into the weekend.
Gold retreats toward $2,500 ahead of the weekend
Gold stays under modest bearish pressure and declines toward $2,500 in the American session on Friday. The 10-year US Treasury bond yield edges higher toward 3.9% after US PCE inflation data, causing XAU/USD to stretch lower.
Week ahead – Investors brace for NFP amid Fed rate cut speculation
Here comes another NFP week, with investors eagerly awaiting the results as they try to discern the size and pace of the Fed’s forthcoming rate cuts. The weaker than expected July numbers triggered market turbulence, instilling fears about a potential recession in the US.
Easing Eurozone inflation to back an ECB rate cut in September Premium
Eurostat will publish the preliminary estimate of the August Eurozone Harmonized Index of Consumer Prices on Friday, and the anticipated outcome will back up the case for another European Central Bank interest rate cut when policymakers meet in September.
Moneta Markets review 2024: All you need to know
VERIFIED In this review, the FXStreet team provides an independent and thorough analysis based on direct testing and real experiences with Moneta Markets – an excellent broker for novice to intermediate forex traders who want to broaden their knowledge base.